HUNT RONALD
Insider CIK 1247851 · WHRT 10% owner · CMRX 10% owner · STIM Director, 10% owner · MEIP 10% owner · CNCE 10% owner · IRTC 10% owner · RLYP Director · VSAR 10% owner · DRTX Director, 10% owner · OXFD · ITRM Director, 10% owner · HARP Director, 10% owner · RLYB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RLYB Rallybio Corp | M Exercise deriv | 2026-10-29 | 2026-11-02 | 2,062 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | M Exercise deriv | 2026-10-29 | 2026-11-02 | 9,196 | $5.60 | $51.5K | 0 | SEC↗ |
| RLYB Rallybio Corp | M Exercise deriv | 2026-10-29 | 2026-11-02 | 3,562 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | M Exercise | 2026-10-29 | 2026-11-02 | 2,062 | $15.28 | $31.5K | 14,820 | SEC↗ |
| RLYB Rallybio Corp | M Exercise | 2026-10-29 | 2026-11-02 | 9,196 | $7.60 | $69.9K | 12,758 | SEC↗ |
| RLYB Rallybio Corp | M Exercise | 2026-10-29 | 2026-11-02 | 3,562 | $2.38 | $8.5K | 3,562 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2026-02-18 | 2026-02-20 | 14,305 | $3.60 | $51.5K | 14,305 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2025-05-13 | 2025-05-15 | 28,500 | — | $0 | 28,500 | SEC↗ |
| ITRM Iterum Therapeutics plc | J Other deriv | 2025-01-13 | 2025-01-23 | 0 | $2208000.00 | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | J Other deriv | 2025-01-13 | 2025-01-23 | 0 | $792000.00 | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2025-01-02 | 2025-01-06 | 73,571 | $0.70 | $51.5K | 73,571 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2024-08-06 | 2024-08-12 | 65,481 | — | $0 | 65,481 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2024-08-06 | 2024-08-12 | 65,481 | — | $0 | 65,481 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2024-08-06 | 2024-08-12 | 130,962 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2024-08-06 | 2024-08-12 | 364,906 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2024-08-06 | 2024-08-12 | 182,453 | — | $0 | 182,453 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2024-08-06 | 2024-08-12 | 182,453 | — | $0 | 182,453 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2024-08-06 | 2024-08-12 | 182,453 | — | $0 | 253,898 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2024-08-06 | 2024-08-12 | 65,481 | — | $0 | 91,122 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2024-05-15 | 2024-05-17 | 16,500 | — | $0 | 16,500 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-11 | 1,016 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-11 | 299,430 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-11 | 686,000 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-11 | 2,300 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-11 | 3,214 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-11 | 2,033 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-11 | 85,750 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer | 2024-03-11 | 2024-03-11 | 10,000 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer | 2024-03-11 | 2024-03-11 | 395,783 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer | 2024-03-11 | 2024-03-11 | 1,463,386 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer | 2024-03-11 | 2024-03-11 | 13,224 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award | 2024-03-08 | 2024-03-11 | 424 | — | $0 | 13,224 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2024-01-02 | 2024-01-04 | 29,096 | $1.77 | $51.5K | 29,096 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award | 2024-01-01 | 2024-01-03 | 1,072 | — | $0 | 12,801 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award | 2023-11-27 | 2023-11-28 | 5,000 | — | $0 | 11,729 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy deriv | 2023-10-25 | 2023-10-27 | 686,000 | — | $0 | 686,000 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy deriv | 2023-10-25 | 2023-10-27 | 85,750 | — | $0 | 85,750 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy | 2023-10-25 | 2023-10-27 | 171,500 | — | $0 | 395,783 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy | 2023-10-25 | 2023-10-27 | 1,372,000 | — | $0 | 1,463,386 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2023-10-01 | 2023-10-02 | 5,479 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2023-10-01 | 2023-10-02 | 5,479 | — | $0 | 14,346 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award | 2023-10-01 | 2023-10-02 | 3,035 | — | $0 | 6,729 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2023-07-01 | 2023-07-03 | 2,796 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2023-07-01 | 2023-07-03 | 2,796 | — | $0 | 8,867 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award | 2023-07-01 | 2023-07-06 | 18,656 | — | $0 | 36,941 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2023-06-22 | 2023-06-23 | 23,000 | — | $0 | 23,000 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2023-05-17 | 2023-05-19 | 15,490 | — | $0 | 15,490 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2023-04-01 | 2023-04-03 | 2,041 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2023-04-01 | 2023-04-03 | 2,041 | — | $0 | 6,071 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award | 2023-04-01 | 2023-04-04 | 18,285 | — | $0 | 18,285 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy deriv | 2023-03-23 | 2023-03-27 | 2,994,305 | — | $0 | 2,994,305 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy | 2023-03-23 | 2023-03-27 | 10,000 | $1000.00 | $10.00M | 10,000 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2023-01-03 | 2023-01-05 | 11,099 | — | $0 | 11,099 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2023-01-01 | 2023-01-04 | 1,197 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2023-01-01 | 2023-01-04 | 1,197 | — | $0 | 4,030 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2022-12-23 | 2022-12-28 | 5,479 | — | $0 | 5,479 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2022-09-25 | 2022-09-27 | 2,796 | — | $0 | 2,796 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2022-06-25 | 2022-06-28 | 30,623 | — | $0 | 30,623 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2022-06-23 | 2022-06-24 | 36,798 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2022-06-23 | 2022-06-24 | 36,798 | — | $0 | 42,501 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 32,142 | $1.40 | $45.0K | 32,142 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 10,167 | — | $0 | 10,167 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2022-06-15 | 2022-06-17 | 647,059 | $0.01 | $6.5K | 647,059 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2022-05-24 | 2022-05-26 | 13,440 | — | $0 | 13,440 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2022-03-25 | 2022-03-29 | 17,955 | — | $0 | 17,955 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2022-01-03 | 2022-01-05 | 6,242 | — | $0 | 6,242 | SEC↗ |
| RLYB Rallybio Corp | P Buy | 2021-08-02 | 2021-08-04 | 153,846 | $13.00 | $2.00M | 2,301,603 | SEC↗ |
| RLYB Rallybio Corp | P Buy | 2021-08-02 | 2021-08-04 | 153,846 | $13.00 | $2.00M | 2,147,757 | SEC↗ |
| RLYB Rallybio Corp | J Other deriv | 2021-07-28 | 2021-08-04 | 2,157,838 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | J Other deriv | 2021-07-28 | 2021-08-04 | 8,742,654 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | J Other deriv | 2021-07-28 | 2021-08-04 | 1,795,946 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2021-07-28 | 2021-08-04 | 13,440 | — | $0 | 13,440 | SEC↗ |
| RLYB Rallybio Corp | J Other | 2021-07-28 | 2021-08-04 | 1,993,911 | — | $0 | 1,993,911 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2021-06-23 | 2021-06-25 | 36,798 | — | $0 | 36,798 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2021-05-04 | 2021-05-07 | 10,167 | — | $0 | 10,167 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2021-05-04 | 2021-05-07 | 4,807 | — | $0 | 4,807 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2021-05-04 | 2021-05-14 | 4,658 | — | $0 | 4,658 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2021-05-04 | 2021-05-14 | 10,167 | — | $0 | 10,167 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy | 2021-01-11 | 2021-08-12 | 235,294 | $17.00 | $4.00M | 913,860 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2020-07-01 | 2020-07-02 | 5,703 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2020-07-01 | 2020-07-02 | 5,703 | — | $0 | 5,703 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2020-05-28 | 2020-06-01 | 4,906 | — | $0 | 4,906 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2020-05-28 | 2020-06-01 | 10,167 | — | $0 | 10,167 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2020-01-21 | 2020-01-23 | 0 | $2208000.00 | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2020-01-21 | 2020-01-23 | 0 | $792000.00 | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2019-06-13 | 2019-06-17 | 5,703 | — | $0 | 5,703 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2019-06-03 | 2019-06-05 | 10,167 | — | $0 | 10,167 | SEC↗ |
| STIM Neuronetics, Inc. | A Award | 2019-04-01 | 2019-04-03 | 847 | $14.75 | $12.5K | 847 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-14 | 464,281 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-14 | 464,281 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-14 | 1,564,272 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion | 2019-02-12 | 2019-02-14 | 464,281 | — | $0 | 2,028,553 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion | 2019-02-12 | 2019-02-14 | 1,564,272 | — | $0 | 1,564,272 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion | 2019-02-12 | 2019-02-14 | 464,281 | — | $0 | 464,281 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy | 2019-02-12 | 2019-02-14 | 214,285 | $14.00 | $3.00M | 678,566 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy | 2019-02-12 | 2019-02-14 | 214,286 | $14.00 | $3.00M | 2,242,839 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2019-02-07 | 2019-03-29 | 4,923 | — | $0 | 4,923 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2018-12-19 | 2019-02-14 | 20,335 | — | $0 | 20,335 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy deriv | 2018-11-09 | 2019-02-14 | 464,281 | — | $0 | 464,281 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy deriv | 2018-11-09 | 2019-02-14 | 464,281 | — | $0 | 464,281 | SEC↗ |
| STIM Neuronetics, Inc. | A Award deriv | 2018-07-02 | 2018-07-05 | 8,767 | — | $0 | 8,767 | SEC↗ |
| STIM Neuronetics, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-05 | 848,360 | — | $0 | 0 | SEC↗ |
| STIM Neuronetics, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-05 | 421,681 | — | $0 | 0 | SEC↗ |
| STIM Neuronetics, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-05 | 66,694 | — | $0 | 0 | SEC↗ |
| STIM Neuronetics, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-05 | 206,380 | — | $0 | 0 | SEC↗ |
| STIM Neuronetics, Inc. | C Conversion | 2018-07-02 | 2018-07-05 | 421,681 | — | $0 | 1,476,421 | SEC↗ |
| STIM Neuronetics, Inc. | C Conversion | 2018-07-02 | 2018-07-05 | 66,694 | — | $0 | 1,543,115 | SEC↗ |
| STIM Neuronetics, Inc. | C Conversion | 2018-07-02 | 2018-07-05 | 848,360 | — | $0 | 848,360 | SEC↗ |
| STIM Neuronetics, Inc. | C Conversion | 2018-07-02 | 2018-07-05 | 206,380 | — | $0 | 1,054,740 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-31 | 466,793 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-31 | 148,603 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-31 | 178,230 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-31 | 178,230 | — | $0 | 645,023 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-31 | 148,603 | — | $0 | 793,626 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-05-30 | 2018-05-31 | 278,062 | $13.00 | $3.61M | 1,071,688 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-31 | 466,793 | — | $0 | 466,793 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-05-30 | 2018-05-31 | 384,615 | $13.00 | $5.00M | 384,615 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2018-05-24 | 2018-05-29 | 11,241 | — | $0 | 11,241 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | C Conversion deriv | 2016-10-25 | 2016-10-25 | 190,154 | — | $0 | 0 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | C Conversion deriv | 2016-10-25 | 2016-10-25 | 610,136 | — | $0 | 0 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | C Conversion deriv | 2016-10-25 | 2016-10-25 | 155,548 | — | $0 | 0 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | C Conversion deriv | 2016-10-25 | 2016-10-25 | 72,389 | — | $0 | 0 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | P Buy | 2016-10-25 | 2016-10-25 | 25,000 | $17.00 | $425.0K | 1,741,589 | SEC↗ |
| IRTC iRhythm Technologies, Inc. | C Conversion | 2016-10-25 | 2016-10-25 | 1,716,589 | — | $0 | 1,716,589 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2015-03-24 | 2015-03-26 | 1,601,390 | $1.97 | $3.15M | 0 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2014-12-18 | 2014-12-22 | 150,000 | $19.01 | $2.85M | 2,409,374 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2014-12-09 | 2014-12-10 | 70,081 | $6.01 | $421.2K | 1,601,390 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2014-12-08 | 2014-12-10 | 9,004 | $6.05 | $54.5K | 1,671,471 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2014-11-11 | 2014-11-13 | 800,000 | $19.37 | $15.50M | 2,559,374 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2014-09-29 | 2014-10-01 | 12,556 | $20.02 | $251.4K | 3,359,374 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | A Award deriv | 2014-05-21 | 2014-05-23 | 8,575 | — | $0 | 8,575 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-27 | 2014-03-28 | 8,439,620 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-27 | 2014-03-28 | 1,349,433 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-27 | 2014-03-28 | 20,942,466 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-27 | 2014-03-28 | 3,546,094 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-27 | 2014-03-28 | 3,050,019 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | X Exercise deriv | 2014-03-27 | 2014-03-28 | 759,565 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-27 | 2014-03-28 | 759,565 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | P Buy | 2014-03-27 | 2014-03-28 | 60,000 | $21.02 | $1.26M | 3,371,930 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-27 | 2014-03-28 | 1,821,084 | — | $0 | 1,821,084 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-27 | 2014-03-28 | 66,049 | — | $0 | 3,311,930 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-27 | 2014-03-28 | 308,356 | — | $0 | 3,245,881 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-27 | 2014-03-28 | 117,342 | — | $0 | 2,937,525 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-27 | 2014-03-28 | 265,219 | — | $0 | 2,820,183 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-27 | 2014-03-28 | 733,880 | — | $0 | 2,554,964 | SEC↗ |
| CMRX CHIMERIX INC | J Other | 2014-03-18 | 2014-03-20 | 700,000 | — | $0 | 1,543,394 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 442,478 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 77,522 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 13,721 | — | $0 | 107,327 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 78,315 | — | $0 | 93,606 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2013-11-21 | 2013-11-25 | 365,000 | $8.25 | $3.01M | 1,680,475 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 125,067 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 259,676 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 378,773 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 497,093 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 541,960 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2013-11-20 | 2013-11-20 | 25,977 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | J Other deriv | 2013-11-20 | 2013-11-20 | 25,977 | — | $0 | 25,977 | SEC↗ |
| RLYP Relypsa Inc | J Other deriv | 2013-11-20 | 2013-11-20 | 17,671 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | F Tax w/h | 2013-11-20 | 2013-11-20 | 21,691 | $11.00 | $238.6K | 1,928,912 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 497,093 | — | $0 | 497,093 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 381,733 | — | $0 | 878,826 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 378,773 | — | $0 | 1,257,599 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 541,960 | — | $0 | 1,799,559 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 125,067 | — | $0 | 1,924,626 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2013-11-20 | 2013-11-20 | 25,977 | $9.18 | $238.5K | 1,950,603 | SEC↗ |
| RLYP Relypsa Inc | P Buy | 2013-11-20 | 2013-11-20 | 185,978 | $11.00 | $2.05M | 2,114,890 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2013-05-08 | 2013-05-08 | 100,000 | $8.45 | $845.0K | 2,045,475 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2013-05-06 | 2013-05-08 | 100,000 | $8.70 | $870.0K | 2,145,475 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2013-04-19 | 2013-04-22 | 157,300 | $8.43 | $1.33M | 2,245,475 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2013-04-18 | 2013-04-22 | 100,000 | $8.57 | $857.0K | 2,402,775 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2013-02-19 | 2013-02-20 | 300,000 | $6.80 | $2.04M | 2,502,775 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2013-02-15 | 2013-02-20 | 197,225 | $6.60 | $1.30M | 2,802,775 | SEC↗ |
| WHRT WORLD HEART CORP | D To issuer deriv | 2012-08-02 | 2012-08-06 | 2,341,920 | $0.10 | $234.2K | 0 | SEC↗ |
| WHRT WORLD HEART CORP | D To issuer | 2012-08-02 | 2012-08-06 | 6,063,603 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | C Conversion deriv | 2012-07-24 | 2012-07-26 | 17,953,008 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | P Buy | 2012-07-24 | 2012-07-26 | 784,313 | $9.00 | $7.06M | 3,028,439 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | C Conversion | 2012-07-24 | 2012-07-26 | 2,244,126 | — | $0 | 2,244,126 | SEC↗ |